D. E. Shaw & Co. Inc. Cuts Position in Pediatrix Medical Group, Inc. (NYSE:MD)

D. E. Shaw & Co. Inc. lowered its holdings in Pediatrix Medical Group, Inc. (NYSE:MD) by 7.8% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm owned 2,143,496 shares of the company’s stock after selling 182,007 shares during the quarter. D. E. Shaw & Co. Inc.’s holdings in Pediatrix Medical Group were worth $28,123,000 as of its most recent filing with the SEC.

Several other institutional investors also recently made changes to their positions in the stock. Pacer Advisors Inc. acquired a new stake in Pediatrix Medical Group in the fourth quarter valued at $35,492,000. American Century Companies Inc. boosted its position in shares of Pediatrix Medical Group by 628.2% in the 4th quarter. American Century Companies Inc. now owns 1,739,323 shares of the company’s stock worth $22,820,000 after buying an additional 1,500,485 shares in the last quarter. Oberweis Asset Management Inc. acquired a new stake in Pediatrix Medical Group in the 4th quarter valued at about $6,122,000. Renaissance Technologies LLC increased its holdings in Pediatrix Medical Group by 117.4% during the 4th quarter. Renaissance Technologies LLC now owns 838,800 shares of the company’s stock valued at $11,005,000 after acquiring an additional 453,000 shares in the last quarter. Finally, Boston Partners increased its holdings in Pediatrix Medical Group by 25.2% during the 4th quarter. Boston Partners now owns 1,956,353 shares of the company’s stock valued at $25,922,000 after acquiring an additional 393,600 shares in the last quarter. 97.71% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

Several research firms have recently commented on MD. UBS Group increased their price target on shares of Pediatrix Medical Group from $16.50 to $18.50 and gave the company a “neutral” rating in a research report on Friday, February 21st. StockNews.com raised Pediatrix Medical Group from a “hold” rating to a “buy” rating in a research note on Wednesday, January 22nd. Truist Financial dropped their price target on Pediatrix Medical Group from $18.00 to $16.00 and set a “hold” rating for the company in a research report on Friday, April 11th. Finally, Macquarie upped their price objective on Pediatrix Medical Group from $19.00 to $20.00 and gave the company an “outperform” rating in a research report on Thursday. Four equities research analysts have rated the stock with a hold rating and three have issued a buy rating to the company. Based on data from MarketBeat.com, Pediatrix Medical Group has a consensus rating of “Hold” and an average price target of $17.08.

Pediatrix Medical Group Stock Performance

NYSE:MD opened at $14.63 on Monday. The company has a debt-to-equity ratio of 0.81, a current ratio of 1.60 and a quick ratio of 1.42. The firm has a market cap of $1.26 billion, a PE ratio of -12.19, a P/E/G ratio of 1.74 and a beta of 1.26. The firm has a 50 day simple moving average of $13.70 and a 200-day simple moving average of $14.05. Pediatrix Medical Group, Inc. has a 1-year low of $6.62 and a 1-year high of $17.67.

Pediatrix Medical Group (NYSE:MD) last issued its quarterly earnings results on Tuesday, May 6th. The company reported $0.33 earnings per share for the quarter, beating the consensus estimate of $0.25 by $0.08. Pediatrix Medical Group had a positive return on equity of 15.47% and a negative net margin of 4.92%. The company had revenue of $458.36 million during the quarter, compared to the consensus estimate of $451.44 million. During the same period in the previous year, the firm posted $0.20 EPS. Pediatrix Medical Group’s revenue was down 7.4% on a year-over-year basis. On average, equities analysts expect that Pediatrix Medical Group, Inc. will post 1.38 EPS for the current year.

Pediatrix Medical Group Profile

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.